Status:
UNKNOWN
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Rectal Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
In patients with advanced rectal cancer, molecular subtypes will be identified by preoperative biopsy, CT, MRI / PET radiomics analysis, clinical features, and clinical features will be confirmed and ...
Eligibility Criteria
Inclusion
- Age: 20-80 years
- Patients diagnosed with mid-lower rectal cancer and expected to receive chemoradiotherapy before surgery
Exclusion
- Patients with distal metastases confirmed at diagnosis
- Patients with other bowel diseases such as IBD, ischemic colitis and TB colitis in addition to colorectal cancer
- If patients do not agree with this study
Key Trial Info
Start Date :
March 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04287400
Start Date
March 5 2019
End Date
December 1 2025
Last Update
September 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Goyang-si, Gyeonggi-do, South Korea, 410-769